Cross-Sector entity
FDA is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. Coverage clusters in consumer-trends, which accounts for 1 of those 3, with the remainder spread across 2 other categories. ibuprofen appears in 3 tracked Cross-Sector stories from March 20, 2026.
3 verified stories tracked
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
FDA is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. Coverage clusters in consumer-trends, which accounts for 1 of those 3, with the remainder spread across 2 other categories. ibuprofen appears in 3 tracked Cross-Sector stories from March 20, 2026. The tracked stories average 3 original sources each.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering ibuprofen. Shared-story counts are live from our verified record — not editorial picks.
Retail Removal
Pharmacies and major retailers initiate the physical removal of affected lot numbers from inventory.
FDA Confirmation
The FDA confirms the recall of 90,000 bottles and provides guidance for consumers and retailers.
Initial Recall Reports
News of a large-scale pediatric ibuprofen recall begins to circulate nationwide.
The FDA has initiated a nationwide recall of nearly 90,000 bottles of children's ibuprofen, forcing major retailers and e-commerce platforms to purge inventory. This large-scale safety action highlights critical vulnerabilities in pediatric pharmaceutical supply chains and consumer trust.
Source: kgw.com · localmemphis.com
The FDA has announced a nationwide recall of approximately 90,000 bottles of children's ibuprofen due to potential safety risks and manufacturing concerns. This large-scale action highlights ongoing challenges in pediatric pharmaceutical quality control and could impact the availability of essential fever reducers.
The FDA has initiated a nationwide recall of approximately 90,000 bottles of children's ibuprofen, citing significant safety concerns. This large-scale action highlights the critical importance of pediatric dosage accuracy and the role of digital supply chain tracking in modern healthcare.
Source: wbir.com · fox13news.com
